185 related articles for article (PubMed ID: 27061417)
1. Pharmacokinetic variations in cancer patients with liver dysfunction: applications and challenges of pharmacometabolomics.
Aboel Dahab A; El-Hag D; Moutamed GM; Aboel Dahab S; Abuknesha R; Smith NW
Cancer Chemother Pharmacol; 2016 Sep; 78(3):465-89. PubMed ID: 27061417
[TBL] [Abstract][Full Text] [Related]
2. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics.
Mussap M; Loddo C; Fanni C; Fanos V
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):115-134. PubMed ID: 31958027
[No Abstract] [Full Text] [Related]
4. Metabolomics as a tool for drug discovery and personalised medicine. A review.
Mastrangelo A; Armitage EG; García A; Barbas C
Curr Top Med Chem; 2014; 14(23):2627-36. PubMed ID: 25515755
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication.
Jian J; He D; Gao S; Tao X; Dong X
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004434
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic variability of anticancer agents.
Undevia SD; Gomez-Abuin G; Ratain MJ
Nat Rev Cancer; 2005 Jun; 5(6):447-58. PubMed ID: 15928675
[TBL] [Abstract][Full Text] [Related]
8. Pharmacometabolomics informs Pharmacogenomics.
Neavin D; Kaddurah-Daouk R; Weinshilboum R
Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27516730
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
10. Pharmacometabonomics in humans: a new tool for personalized medicine.
Everett JR
Pharmacogenomics; 2015; 16(7):737-54. PubMed ID: 25929853
[TBL] [Abstract][Full Text] [Related]
11. Adaptive control methods for the dose individualisation of anticancer agents.
Rousseau A; Marquet P; Debord J; Sabot C; Lachâtre G
Clin Pharmacokinet; 2000 Apr; 38(4):315-53. PubMed ID: 10803455
[TBL] [Abstract][Full Text] [Related]
12. Pharmacometabolomics-aided Pharmacogenomics in Autoimmune Disease.
Katsila T; Konstantinou E; Lavda I; Malakis H; Papantoni I; Skondra L; Patrinos GP
EBioMedicine; 2016 Mar; 5():40-5. PubMed ID: 27077110
[TBL] [Abstract][Full Text] [Related]
13. Pharmacometabonomics: The Prediction of Drug Effects Using Metabolic Profiling.
Everett JR
Handb Exp Pharmacol; 2019; 260():263-299. PubMed ID: 31823071
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine into health national services: barriers and potentialities.
Rodríguez Vicente AE; Herrero Cervera MJ; Bernal ML; Rojas L; Peiró AM
Drug Metab Pers Ther; 2018 Dec; 33(4):159-163. PubMed ID: 30391933
[TBL] [Abstract][Full Text] [Related]
15. A case of personalized and precision medicine: Pharmacometabolomic applications to rare cancer, microbiological investigation, and therapy.
Cristoni S; Bernardi LR; Malvandi AM; Larini M; Longhi E; Sortino F; Conti M; Pantano N; Puccio G
Rapid Commun Mass Spectrom; 2021 Jan; 35(2):e8976. PubMed ID: 33053249
[TBL] [Abstract][Full Text] [Related]
16. Integration of pharmacometabolomics with pharmacokinetics and pharmacodynamics: towards personalized drug therapy.
Kantae V; Krekels EHJ; Esdonk MJV; Lindenburg P; Harms AC; Knibbe CAJ; Van der Graaf PH; Hankemeier T
Metabolomics; 2017; 13(1):9. PubMed ID: 28058041
[TBL] [Abstract][Full Text] [Related]
17. Metabolomics as a Tool to Understand Pathophysiological Processes.
Ivanisevic J; Thomas A
Methods Mol Biol; 2018; 1730():3-28. PubMed ID: 29363062
[TBL] [Abstract][Full Text] [Related]
18. Pharmacometabolomics of Asthma as a Road Map to Precision Medicine.
Kelly RS; Cote MF; Begum S; Lasky-Su J
Handb Exp Pharmacol; 2023; 277():247-273. PubMed ID: 36271166
[TBL] [Abstract][Full Text] [Related]
19. Pharmaco-metabolomics: an emerging "omics" tool for the personalization of anticancer treatments and identification of new valuable therapeutic targets.
Corona G; Rizzolio F; Giordano A; Toffoli G
J Cell Physiol; 2012 Jul; 227(7):2827-31. PubMed ID: 22105661
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
